SGMT Overview

Company Profile

Related stocks

CBIO • United States

Crescent Biopharma, Inc.

14.91 USD

553.86M USD 1Y +17.1%

SGP • United States

SpyGlass Pharma, Inc.

24.92 USD

833.52M USD

JBIO • United States

Jade Biosciences, Inc.

14.39 USD

915.17M USD 1Y +55.8%

ODTX • United States

Odyssey Therapeutics, Inc.

19 USD

913.11M USD

SPTX • United States

Seaport Therapeutics, Inc.

18.15 USD

971.58M USD

AKTS • United States

Aktis Oncology, Inc.

18.15 USD

1.01B USD

AVLN • United States

Avalyn Pharma Inc.

25.76 USD

1.14B USD

TRAX • United States

First Tracks Biotherapeutics, I

31.85 USD

1.14B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

148.8% p.a.

Max Drawdown (3Y)

-89.7%

Sharpe Ratio (3Y)

0.01

Beta Factor

3.49

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

High market risk: Beta of 3.49 indicates above-average volatility compared to the broader market.